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Schistosome worms have been infecting humans for millennia, but it is only in the last
half century that we have begun to understand the complexities of this inter-relationship.
As our sophistication about the inner workings of every aspect of the immune system
has increased, it has also become obvious that schistosome infections have broad
ranging effects on nearly all of the innate and adaptive immune response mechanisms.
Selective pressures on both the worms and their hosts, has no doubt led to co-evolution
of protective mechanisms, particularly those that favor granuloma formation around
schistosome eggs and immune suppression during chronic infection. The immune
modulatory effects that chronic schistosome infection and egg deposition elicit have been
intensely studied, not only because of their major implications to public health issues, but
also due to the emerging evidence that schistosome infection may protect humans from
severe allergies and autoimmunity. Mouse models of schistosome infection have been
extremely valuable for studying immune modulation and regulation, and in the discovery
of novel aspects of immunity. A progression of immune reactions occurs during granuloma
formation ranging from innate inflammation, to activation of each branch of adaptive
immune response, and culminating in systemic immune suppression and granuloma
fibrosis. Although molecular factors from schistosome eggs have been identified as
mediators of immune modulation and suppressive functions of T and B cells, much work
is still needed to define the mechanisms of the immune alteration and determine whether
therapies for asthma or autoimmunity could be developed from these pathways.
Keywords: T helper lymphocytes, immune regulation, hygiene hypothesis, soluble egg antigen, sialyl Lewisx
glycans
INTRODUCTION
Schistosoma mansoni, Schistosoma haematobium, and Schistosoma
japonicum are helminth worm species that infect humans and are
highly prevalent in warm climates. They are obligate parasites that
require a supply of blood from mammalian hosts to mature from
larval stages to adult worms. Schistosomes live within the body of
their hosts where they attach to the walls of intestinal blood vessels
for feeding. Adult male and female schistosomes form copulating
pairs that can produce asmany as 300 eggs per couple per day. The
eggs only hatch in fresh water, and the first larval form requires
the presence of freshwater snails in order to mature into cer-
cariae, the larval form that infects humans and other mammals.
Unfortunately, a large portion of the eggs that are produced enter
the portal circulation instead of leaving the body and deposit in
internal organs, particularly the liver. As will be described inmore
detail later in this review, the immune system of the host rec-
ognizes schistosome eggs as foreign and responds with a local
granulomatous response and systemic changes to immunity. The
ability of adult schistosome worms to persist in their hosts and the
resulting continual production of eggs and their antigens drives
the adaptive immune system toward a highly regulatory response
that has repercussions to overall immunity.
MODELING OF SCHISTOSOME EGG GRANULOMA
FORMATION IN MICE
Most of what is known about the mechanisms by which schis-
tosome granulomas form and function has come from the use
of mouse models, especially in response to Schistosoma mansoni
eggs (Boros, 1989). Schistosome cercariae can infect most if not all
mammalian hosts and mice have proven very useful for studying
granulomatous responses due to significant similarities with the
human immune system, the availability of a vast array of reagents,
and the production of many immunogenetically altered mouse
strains that aid in mechanistic studies. The classic model used to
study granuloma formation involves infection with schistosome
cercariae, the larval form that infects humans, either through
skin exposure or direct subcutaneous injection into the mouse.
Adult worm pairs produce eggs continuously resulting in asyn-
chronous granuloma formation. The natural infection model has
been very useful in the study of the dynamics of the immune
response, pathology, and granuloma architecture, but has some
limitations due to its asynchronous nature. To study temporal
aspects of egg deposition and granuloma formation, other mod-
els were developed in which purified schistosome eggs, or egg
antigens coated to beads or macromolecular compounds were
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injected into the tail veins of mice (Boros and Warren, 1971b).
The intravenous injection model results in egg deposition pri-
marily in the lungs, where the granulomas form simultaneously
and temporal changes in the immune response can be more easily
tracked. Differences have been noted between lung versus hep-
atic granulomas, and between the differing species of schistosome
worms. Therefore, it is important to consider the route and form
of administration, localization of granuloma formation, and the
infectious agent when interpreting results.
THE SCHISTOSOME EGG GRANULOMA: A NECESSARY EVIL
Schistosome eggs have an outer shell made of chitin that houses
the larval form, miracidiae, which is responsible for the release
of soluble egg antigens (SEA). The miracidiae do not hatch in
the host tissues, but production of SEA while the larvae are still
viable stimulates the host immune response to form a granuloma
(Boros and Warren, 1970). Using the temporal induction mod-
els, it was determined that the initial response to egg deposition
and SEA release in small blood vessels involves the local produc-
tion of inflammatory cytokines (TNFα, IL-1) and chemokines
from resident epithelial cells andmacrophages (Joseph and Boros,
1993; Lukacs et al., 1993; Wynn et al., 1993; Burke et al., 2010).
This triggers the early influx of monocytes, neutrophils, and lym-
phocytes and the establishment of schistosome egg granulomas.
Each schistosome egg and its individual granuloma do not pose
much of a threat to the host. Over time, however, the constant
deposition of eggs and formation of granulomas leads to hep-
atosplenomegaly and significant blockage of portal blood flow
(Boros, 1989). Portal hypertension promotes the development
of intestinal and esophageal varices resulting in severe bleeding
and eventually can lead to the death of the infected individ-
ual. Schistosome egg granulomas were therefore viewed as major
contributors to the pathogenesis of schistosome infection and
strategies were sought to inhibit or prevent granuloma formation.
Several lines of evidence demonstrated that granuloma forma-
tion in response to SEA was dependent on the activation of CD4+
T helper (TH) lymphocytes and also highlighted the importance
of granuloma formation to host survival. Infection of athymic
nude mice led to substantially decreased granuloma size and
impairment of the anti-SEA antibody response (Phillips et al.,
1977; Amsden et al., 1980). Elimination of TH cells by treatment
with anti-lymphocyte serum or the specific, complement-fixing
anti-CD4 antibody, L3T4, led to decreased granuloma formation
and IL-2 production by spleen cells of infected mice (Domingo
and Warren, 1968; Mathew and Boros, 1986). The severe absence
of granuloma formation following high efficiency anti-CD4-
depletion inmice led to the influx of low numbers ofmacrophages
or eosinophils, diminished collagen deposition around eggs and
increased damage to local hepatocytes (Mathew and Boros, 1986;
Fallon et al., 2000b). Further evidence of the critical importance
of TH cell-mediated granuloma formation came from studies of
infection in thymectomized mice and mice receiving additional
T cell ablative therapies in which severe inhibition of granuloma
formation led to mortality due to increased liver damage (Lucas
et al., 1980; Fallon and Dunne, 1999). Toxicity to hepatocytes
in the absence of granuloma formation has been attributed to
the hepatotoxic cationic glycoproteins, α1 and ω1, released by
schistosome eggs as part of SEA (Dunne et al., 1991; Abdulla et al.,
2011). The mechanisms by which granulomas prevent direct hep-
atotoxicity have yet to be shown definitively, but of potential
interest is a recent finding that the glycosylated T2 ribonucle-
ase ω1 binds to the mannose receptor, a C-type lectin expressed
by macrophages and dendritic cells (DC) (Dewals et al., 2010;
Everts et al., 2012). Binding and internalization of ω1 through
the mannose receptor on DC leads to polarization of these anti-
gen presenting cells toward a TH2 inducing phenotype (Everts
et al., 2009, 2012). Therefore, infiltration of macrophages and
DC into granulomas in the liver appears to be one host protec-
tive mechanism for binding and neutralizing hepatotoxic glycans
from the schistosome egg and surrounding tissue and for the
ultimate survival of the host. At the same time, the response to
ω1 by DC and macrophages drives the TH2 immune response
leading to increased lymphocyte and eosinophil infiltration and
enlargement of the granuloma (Everts et al., 2009; Steinfelder
et al., 2009). As will be discussed below, this TH2 dominated
response may also be an adaptive mechanism of protection of
the host from deleterious prolonged TH1 mediated immunity.
Chronic schistosome infection leads to further modulation of
the immune response going from an acute TH2 reaction toward
immune regulation and fibrosis.
SCHISTOSOME GRANULOMA FORMATION AS A DYNAMIC
MODEL OF ADAPTIVE IMMUNE RESPONSES
TH1 CELLS MEDIATE EARLY GRANULOMA FORMATION
The role of TH cell-derived cytokines in schistosome granuloma
formation has been intensively studied and reviewed (Scott et al.,
1989; Boros, 1994; Milner et al., 2010). A timeline of the changes
in mouse TH cell responses during the natural infection by schis-
tosome cercariae is given in Figure 1. Following the initial proin-
flammatory cytokine release, CD4+ TH cells enter the lesion and
release TH1-type cytokines, IL-2 and IFNγ, which facilitates the
establishment of delayed-type hypersensitivity response and early
granuloma formation. A series of experiments led to the discov-
ery of antigenic peptides, some that were able to induce TH1-type
immune responses even in the absence of an adjuvant (Lukacs
and Boros, 1991, 1992, 1993; Cai et al., 1996; Chen and Boros,
1998, 2001; Reis et al., 2008). The finding that neutralization of
IL-4 during schistosome infection led to decreased granuloma
formation prompted interest in prolonging TH1 responses during
schistosome infection in order to reduce pathology (Yamashita
and Boros, 1992). Initial results indicated that IL-12 could drive
expression of IFNγ, IL-2, IL-10, and IL-12 in pulmonary gran-
ulomas and could reverse established TH2-type responses in
egg pre-sensitized animals (Wynn et al., 1994). Further studies
indicated that vaccination of mice with eggs plus IL-12 led to
decreased fibrosis similar to that seen in Stat-6 knockout mice
that lacked IL-4 receptor signaling (Wynn et al., 1995; Kaplan
et al., 1998). Much of the IL-12 adjuvant effect was attributed
to induction of IFNγ (Boros and Whitfield, 1998). However,
extreme skewing of the immune response toward schistosome
eggs to a TH1-type reaction resulted in increased mortality and
liver pathology (Boros and Whitfield, 1998; Fallon and Dunne,
1999; Wynn and Hoffmann, 2000). In addition to the deleteri-
ous effects of an overt TH1-type response in mice, it has also been
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FIGURE 1 | Timeline of TH cell mediated responses in the mouse model
of schistosome infection. Subcutaneous injection of schistosome cercariae
on day 0 leads to development of adult worms and egg production beginning
at 4–5 weeks. The early innate and adaptive immune response to adult worm
antigens is dominated by proinflammatory and TH1 cytokines (TNFα, IL-12,
and IFNγ). Following egg deposition in the liver and other internal organs,
the larval miracidiae release soluble egg antigens (SEA) containing molecules
that drive a rapid transition from TH1 to TH2-dominated immunity and
production of IL-4, IL-5, and IL-13. Between 7 and 8 weeks of infection,
FoxP3+ TREG cells and IL-10 are detectable, and the population of splenic
FasL+ CD5+ B cells begins to proliferate. TH2 response and peak granuloma
formation occurs between 8 and 10 weeks of infection and is followed by
granuloma downmodulation and increasing fibrosis around newly deposited
eggs which persists throughout the remainder of infection.
shown that the more severe form of human disease, hepatosplenic
schistosomiasis, is associated with elevated levels of TNFα and
IFNγ and lower levels of the TH2-type cytokine IL-5 (Mwatha
et al., 1998). Thus, although decreased granuloma size and fibro-
sis in TH1 dominated responses appeared to be desirable, it is clear
that the switch to a TH2-type response may have some protective
effect for the host.
TH2 CELLS AND NON-T CELL SOURCES OF IL-4
In the murine model, the cytokine response to worm eggs and
SEA begins to switch to a TH2-type response during the seventh
week post-infection. By 8 weeks of infection, the production of
IL-4 and other TH2 cytokines predominates and IFNγ is barely
detectable. The switch to a TH2-type reaction is accompanied
by a change in the cellularity of the granuloma with a dramatic
influx of eosinophils, mast cells, and fibroblasts into the lesion.
The influx of these cell types results in enlarged granulomas with
increasing fibrosis. The mechanisms underlying this switch in
cytokine pattern have been intensely studied. Neutralization of
IL-4 or infection of IL-4-deficient or IL-4R-deficient mice leads
to decreased TH2-type cytokine production and prolonged TH1
responses (Cheever et al., 1994; Kaplan et al., 1998; Jankovic et al.,
1999). However, in certain murine strains, IL-4 deficiency was
not enough to drive substantial increases in IFNγ production or
to completely prevent development of a TH2-type response dur-
ing infection (Metwali et al., 1996; Rakasz et al., 1998). IL-10
and/or TGF-β were the dominant mediators TH1 downregula-
tion in IL-4 deficient mice (Rakasz et al., 1998). IL-4 deficient
mice display reduced expression of IL-13, but the residual IL-
13 may play a compensatory role for the loss of IL-4 expression
(Chiaramonte et al., 1999b; McKenzie et al., 1999). IL-13 plays a
similar role as IL-4 through binding to the IL-4 receptor and par-
ticipates in granuloma formation, IgE induction, and inhibition
of IFNγ production. In contrast to IL-4, IL-13 is also involved
in the induction of collagen synthesis by granuloma fibroblasts
through binding to the specific IL-13R (Chiaramonte et al., 1999a;
Fallon et al., 2000a). TH1 and TH2 cytokines participate in cross-
regulation of synthesis and function of the opposing cytokine
response, therefore, it was initially unclear how the TH2 response
could be induced while the TH1-type response that downregulates
it was already actively mediating granuloma formation. One pos-
sibility is that IL-12 production from granuloma macrophages is
decreased upon exposure to SEA (Boros, 1999; Todt et al., 2000).
Lacto-N-fucopentaose III (LNFPIII), a glycan component of
SEA, has been shown to act directly on DC and monocytes to
favor the development of the TH2 response (Wang et al., 2010;
Zhu et al., 2012). In comparison to LPS stimulation, LNFPIII
induced an increase in the ratio of CD86/CD80 expression on
DC, a similar pattern of chemokine expression, higher expres-
sion of IL-6 but no IL-12 from purified DC (Wang et al.,
2010). Co-culture of these LNFPIII-stimulated DC with naive
OT-II TH cells led to dominant production of IL-4 and no
IFNγ, but induced similar levels of IFNγ and cytolytic activ-
ity of OT-I CD8+ TC cells following co-culture in comparison
with LPS-stimulated DC (Wang et al., 2010). LNFPIII was also
shown to program macrophages to induce IFNγ production
from NK cells by an IL-12-independent, but CD40/CD40L-
dependent mechanism. Treatment with dextran conjugated to
LNFPIII was successful at inhibiting experimental autoimmune
encephalomyelitis (EAE) in mice through a mechanism involv-
ing alternative activation of CD11b+Ly-6Chigh monocytes (Zhu
et al., 2012). The LNFPIII-treated TCR transgenic 2D2 mice had
elevated levels of IFNγ as well as IL-4, IL-5, IL-13, and IL-10
in response to immunization with MOG peptide in compari-
son with mice that received unconjugated protein (Zhu et al.,
2012). These data demonstrate alternate pathways by which
www.frontiersin.org February 2013 | Volume 4 | Article 39 | 3
Lundy and Lukacs Immune modulation in schistosomiasis
LNFPIII elicits both IFNγ production from NK and CTL cells
while also mediating a TH2 and TREG dominated responses from
CD4+ T cells, and suggest a mechanism for the induction of
TH2 cells in the face of a strong TH1 immune response. The
T2 ribonuclease, ω1, component of SEA was demonstrated to
directly inhibit the activation of DC by LPS, suggesting that
it is a critical factor in the inhibition of the TH1 response
(Everts et al., 2009; Steinfelder et al., 2009).
A study done using SEA stimulation of human basophils was
one of the first in which IL-4 production by these cells was
definitively shown (Falcone et al., 1996). Since that time it has
become evident that basophils are not only capable of produc-
ing IL-4 but are also important antigen presenting cells that can
initiate TH2 responses (Perrigoue et al., 2009; Sokol et al., 2009;
Yoshimoto et al., 2009). The IPSE/α-1 glycoprotein component of
SEA was shown to activate IL-4 production frommouse basophils
through a mechanism dependent on IgE antibodies and FcR
expression (Schramm et al., 2007). Several other groups have also
demonstrated IL-4 production in response to SEA by non-CD4+
peritoneal exudate cells and activated granuloma eosinophils
(Williams et al., 1993; Sabin and Pearce, 1995; Kullberg et al.,
1996; Sabin et al., 1996b; Rumbley et al., 1999). IL-5 is a stimula-
tory cytokine for eosinophils and studies in IL-5 deficient mice
have revealed a reduction in IL-4 production from ionomycin
stimulated non-B, non-T cells from infected mice (Brunet et al.,
1999). However, IL-4 production from SEA-stimulated or IgE
crosslinked non-B, non-T cells of IL-5 deficient mice was com-
parable to normal mice and anti-IL-5 antibody treatment did not
reduce granuloma sizes in infected mice (Sher et al., 1990). These
non-T cell sources of IL-4 may be sufficient to supply the early
IL-4 necessary to down regulate IL-12 and IFNγ production and
to stimulate TH2 cell differentiation.
THE ROLE OF TH17 CELLS IN GRANULOMA PATHOLOGY
The first evidence of a role for IL-17 in schistosome granuloma
formation came from a study in which blockade of the IL-12p40
receptor subunit shared by IL-12 and IL-23, but not the IL-12p35
receptor subunit that is specific to IL-12, led to decreased granu-
loma size (Rutitzky et al., 2005). Granuloma formation correlated
with levels of IL-17 production in susceptible vs. resistant strains
of mice and treatment of susceptible strains with anti-IL-17 neu-
tralizing antibodies led to decreases in granuloma size (Rutitzky
et al., 2005). It was later determined that SEA had direct stim-
ulatory effects on IL-23 and IL-1 production by dendritic cells
(Rutitzky et al., 2008; Shainheit et al., 2008). Mice with genetic
deficiencies of the TH1-specific transcription factor T-bet or IFNγ
displayed enlarged schistosome granulomas and elevated IL-17
levels (Rutitzky et al., 2009; Rutitzky and Stadecker, 2011). The
studies described above were mostly performed using immuniza-
tion with SEA and complete Freund’s adjuvant in the normally
granuloma resistant C57BL/6 strain of mice. IL-4 and type 1
interferons, which may be suppressed by instillation of complete
Freund’s adjuvant, are normally elicited by schistosome eggs and
are known inhibitors of TH17 cells. It will be interesting to deter-
mine whether IL-4 and IFNα or IFNβ display inhibitory effects
on IL-23 or IL-17 during schistosome infection in granuloma
susceptible mice.
B LYMPHOCYTES AND ANTIBODIES
The dynamics of total B cell distribution and their roles during
schistosome infection have also been intensely investigated. It was
found that the absolute numbers of B cells in the spleen, lymph
nodes and blood increased dramatically during the acute TH2
phase of infection and remained high throughout the chronic
infection (Chensue and Boros, 1979; El-Cheikh et al., 1998).
The absolute number of T cells rose slightly in the same organs
leading to a relative decrease in the number of T cells com-
pared to B cells. This expansion of B cells was polyclonal in
nature yielding both antigen-specific and non-specific antibod-
ies, including autoreactive antibodies (Fischer et al., 1981; Lopes
et al., 1990). SEA-specific immunoglobulin production begins
following egg deposition and increases throughout the acute and
chronic downmodulated phases of schistosome infection (Boros
et al., 1975). Evidence of intra-granulomatous antibody produc-
tion exists with IgG1 being the predominant antibody isotypes
released from acute-phase granulomas and a mixture of IgG1,
IgG2a, IgG2b, IgG3, and IgA released by chronic-phase granulo-
mas (Boros et al., 1982). Intralesional production of IgM peaked
at 12–16 weeks of infection while IgG production was highest at
20 weeks of infection (Boros et al., 1982). The role of antibod-
ies in the pathogenesis of schistosome granuloma formation is
complex, with several studies showing an active immune regu-
latory role of antibodies from infected individuals (Goes et al.,
1991; Jankovic et al., 1997, 1998; Rezende et al., 1998). Immune
complexes from the blood of chronically infected human patients
were able to inhibit in vitro granuloma formation (Goes et al.,
1991). This inhibition was dependent on the presence of the Fc
portion of the immunoglobulin and could be reversed by treat-
ment with indomethacin, indicating a role for prostaglandins
in immune suppression mediated by immune complexes (Goes
et al., 1991). Infection of mice deficient in either FcγR or FcR
led to increased size and collagen content of acute-phase and
chronic granulomas (Jankovic et al., 1997, 1998). SEA-specific
antibodies may mediate granuloma downmodulation by arming
FcR positive suppressor cells, or by neutralizing and sequestering
antigens. Another mechanism by which immune complexes may
mediate downmodulation is through inhibition of MHC Class II
expression and disruption of antigen presentation (Rezende et al.,
1998).
Several lines of evidence suggest that immune regulation and
control of granuloma formation may be the primary function
of B cells during schistosome infection. One study demon-
strated that SEA-stimulated mesenteric lymph node cells of B
cell-deficient (JHD) mice produced higher amounts of IFNγ and
IL-12 cytokines and reduced amounts of IL-4 and IL-10 when
stimulated with SEA (Hernandez et al., 1997). Irradiated spleno-
cytes from JHD mice were more effective at eliciting a TH1-type
response from SEA-specific CD4+ T cells. Another study in B
cell-deficient (μMT)mice showed increased mRNA expression of
TH1 cytokines in B-deficient compared to wild-type mice (Ferru
et al., 1998). These authors concluded that the B cell popula-
tion was necessary to drive TH2-type responses during infection.
However, a different study using μMTmice demonstrated only a
reduction in IL-4 production without differences in IL-5, IL-10,
or IFNγ production (Jankovic et al., 1998). In contrast, infection
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of BALB.Xid mice, which have a deficiency in B cell receptor
signaling and severe reductions in the mucosal CD5+ B cell
compartment, revealed a defect in antigen-stimulated IL-10 pro-
duction, reduced SEA-specific IgM and IgA titers, increased IFNγ
and IL-4 production, elevated IgE and IgG1 titers, increased tis-
sue egg burdens and higher mortality (Gaubert et al., 1999).
Thus, B cells appear to play a central role in mediating the
transition from TH1 to TH2 responses and in the regulation
of the granulomatous response during acute and chronic infec-
tion. Antibody-independent regulatory mechanisms of B cells are
discussed below.
SYSTEMIC IMMUNE REGULATION STIMULATED BY
CHRONIC SCHISTOSOME INFECTION
As the TH2 response progresses, SEA-induced and cytokine-
mediated collagen synthesis by granuloma fibroblasts leads to
increased hepatic fibrosis that continues through the remainder
of infection (Boros and Lande, 1983). Schistosome granulomas
reach peak size and cellularity at 8–10 weeks of natural murine
infection. After 10 weeks, a spontaneous diminution of cytokine
responses to SEA and decreased granuloma size (granuloma
downmodulation) is observed leading to a less severe chronic
stage of the murine disease by 14 weeks (Boros et al., 1975;
Colley, 1975). Downmodulation is accompanied by cumulative
hepatic fibrosis and elevated anti-SEA antibody titers (Boros et al.,
1975). Splenectomy of infected mice at 8 weeks of infection led
to increased granuloma size at 12 weeks of infection indicating
that a splenic mechanism was involved in granuloma down-
modulation (Hood and Boros, 1980). Subsequent studies were
directed at identifying the splenic factor(s) involved in granuloma
downmodulation.
The earliest findings showed that spleen cells from chronically
infected mice were able to transfer downmodulation to acutely
infected mice (Colley, 1976; Chensue and Boros, 1979). Depletion
of T cells from spleen cell preparations demonstrated their role
in transferring downmodulation (Chensue and Boros, 1979). A
complex series of experiments followed in which the granuloma
inducing properties of T cells were attributed to TH cells, while
granuloma and SEA-induced suppressive effects were attributed
to both the TH and CD8+ cytotoxic T lymphocyte (CTL) sub-
sets (Chensue et al., 1981; Weinstock and Boros, 1983; Ragheb
and Boros, 1989; Fidel and Boros, 1990). However, a subsequent
study of infection in CTL-deficient mice demonstrated normal
granuloma formation during acute infection and normal down-
modulation during chronic infection (Yap et al., 1997). These
data suggested that although highly purified CTL were capable
of regulating granuloma formation, their presence in vivo was
not critical for controlling the immune response toward schisto-
some eggs. This indicated the importance of CTL-independent
factors in mediating granuloma downmodulation that are now
understood to involve the activation of regulatory populations of
T and B lymphocytes as well as other mechanisms of immune
suppression.
REGULATORY CYTOKINES: IL-10 AND TGF-β
The anti-inflammatory cytokine product of regulatory lympho-
cytes, IL-10, was recognized as an important mediator of the
switch from TH1- to TH2-type response during schistosomiasis in
the early 1990s (Sher et al., 1991; Oswald et al., 1992b). As is now
a widely recognized property of IL-10, early neutralization stud-
ies led to increased MHC Class II and B7-1/B7-2 costimulatory
molecule expression on granuloma macrophages and increased
antigen presentation capacity for TH1 cells (Flores Villanueva
et al., 1993). In a subsequent study, recombinant IL-10 or IL-
10/Fc fusion protein treatment of infected or egg-injected mice
led to decreased granuloma formation, decreased IL-2 and IFN-γ
production, and increased IL-4 and IL-10 production (Flores-
Villanueva et al., 1996). In one study, mice treated with anti-IL-10
antibodies in vivo displayed increased hepatic and pulmonary
granuloma size, increased eosinophilia, and elevated IFN-γ and
IL-5 levels during acute infection (Boros and Whitfield, 1998).
However, another study indicated that granuloma downmodu-
lation was not impaired in IL-10 deficient mice (Wynn et al.,
1998). The same group also showed that infections of IL-10/IL-
4 and IL-10/IL-12 double deficient mice in comparison to mice
with singular deficiencies led to severe immune polarizations to
TH1 and TH2, respectively (Wynn et al., 1997). The double defi-
cient mice died from very distinct pathologic mechanisms with
the IL-10/IL-12 mice that were heavily skewed toward the TH2
response having enlarged and highly fibrotic granulomas (Wynn
et al., 1997; Hoffmann et al., 2000). These data indicated that
IL-10 regulates the TH2 as well as the TH1 response toward schis-
tosome antigens. Production of IL-10 in response to stimulation
with SEA or its major glycan component, lacto-N-fucopentaose
III (LNFPIII), has been attributed to TH cells, B cells and mono-
cytes (Sher et al., 1991; Velupillai et al., 1996a, 1997; Terrazas et al.,
2001).
The role of TGFβ in granuloma pathology is even more
complex than that of IL-10. TGFβ has an inhibitory effect on
macrophages and TH1 cells in the schistosome model (Oswald
et al., 1992a; Qadir et al., 2001). Studies of inhibition of TH cell
responses and schistosome granuloma formation by TGFβ have
the limitation that IL-10 and IL-4 were usually present (Oswald
et al., 1992a; Qadir et al., 2001). In contrast, TGFβ in the con-
text of proinflammatory cytokines acts as an important cofactor
for TH17 cell differentiation, and therefore, can contribute to the
enhanced granuloma formation described in a previous section
(Shainheit et al., 2008). TGFβ also induces the production of con-
nective tissue components by fibroblasts and therefore may play a
role in the development of fibrosis and portal hypertension seen
in severely infected individuals (Wahl et al., 1997).
REGULATORY T LYMPHOCYTES
With the discovery that FoxP3 was the canonical transcription
factor for regulatory T (TREG) cells that produced IL-10 and
TGFβ, it was of interest to study whether the previously observed
effects of chronic granuloma-induced immune suppression were
attributable to TREG cells (Hori et al., 2003). In the natural infec-
tion model with S. mansoni, dramatic and progressive increases
in the expression of FoxP3 mRNA were observed in the liver and
spleen, with peak expression occurring at the 16 week granu-
loma downmodulated stage and highest in the liver (Singh et al.,
2005; Taylor et al., 2006). Additional phenotypic markers of TREG
cells (CD103, GITR, OX40, and CTLA-4) were also elevated
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at the mRNA level in the spleens of schistosome-infected mice
(Layland et al., 2010). Over-expression of FoxP3 through retro-
viral gene transfer at the beginning of egg deposition resulted in
increased expression of IL-4, IFNγ, and TGFβ but not IL-10, yet
resulted in decreased granuloma formation (Singh et al., 2005).
The expansion but low IL-10 expression of FoxP3+ TREG cells was
also observed in a separate study of the natural infection model
(Baumgart et al., 2006). Transfer of immune tolerance by TREG
derived from schistosome infected hosts was IL-10 independent
(Pacifico et al., 2009). These data demonstrate that TREG cells are
activated and recruited by the schistosome granuloma, but that
they are not necessarily the main source of IL-10 during infection,
nor are they dependent on IL-10 for their immune suppressive
functions.
REGULATORY B LYMPHOCYTES
The realization that B cells have regulatory capacity was ini-
tially demonstrated in response to sheep red blood cells and
was associated first with regulatory antibody production and
later linked to interactions with T cells (Stockinger et al., 1979;
Zubler et al., 1980). Subsequent studies in mice and humans have
demonstrated that B lymphocytes can regulate immune responses
through antibody-dependent mechanisms as well as via direct
cell–cell interactions and regulatory cytokine production (Klinker
and Lundy, 2012). The schistosome granuloma model was one of
the first natural infection models in which the regulatory prop-
erties of B lymphocytes were reported (Cheever et al., 1985).
Mice that were genetically deficient in B cells failed to downmod-
ulate granuloma formation around eggs deposited in the liver
during chronic infection and had higher mortality rates than con-
trol mice with normal B cell development (Cheever et al., 1985).
The regulatory properties of B cells in schistosome infection were
originally attributed to the increased production of natural anti-
bodies, which more recently have been demonstrated to play a
role in the clearance of apoptotic cell debris and immune sup-
pression (Chen et al., 2009; Vas et al., 2012). In addition, it
was demonstrated that IL-10 production by B cells, particularly
the CD5+ B-1a cell subset, was induced in vitro by the schisto-
some glycan LNFPIII found in SEA (Velupillai and Harn, 1994;
Velupillai et al., 1996a, 1997). A study of schistosome infection in
Xid mice, which have a severe deficiency in CD5+ B cells, demon-
strated that this subset plays a role in regulating the production
of IFNγ and IL-5 by TH cells and in controlling granuloma size
(Gaubert et al., 1999). IL-10 acts as an autocrine growth factor
for CD5+ B cells and both IL-12 and IFNγ inhibit the expansion
of CD5+ B cells during schistosome infection (Velupillai et al.,
1996b). Redistribution of splenic CD5+ B cells to Peyer’s patches
and mesenteric ganglia during schistosome infection has been
reported, and may be one mechanism by which helminth infec-
tions regulate inflammatory bowel disease (El-Cheikh et al., 1998;
Elliott et al., 2000).
Although most subsets of APC can produce IL-10 in response
to stimulation through CD40 and toll-like receptors, two subsets
of B cells have been identified as the major producers of IL-10 in
mice, B10 and T2-MZP B cells (Evans et al., 2007; Yanaba et al.,
2008). B10 cells have the surface phenotype CD5+CD1dhigh and
may be the cells that responded to stimulation with schistosome
LNFPIII in the previous study (Velupillai et al., 1997; Yanaba et al.,
2008). Stimulation of IL-10 production by T2-MZP cells, which
have the phenotype CD21highCD23+, has not yet been studied
during schistosome infection. B10 and T2-MZP cells have been
used to transfer immune suppression in several models of inflam-
mation in mice, and work is being done to identify the equivalent
of IL-10 producing B10 and T2-MZP cells in human peripheral
blood (Blair et al., 2010; Iwata et al., 2011). Importantly, the reg-
ulatory responses induced by B10 and T2-MZP cells appear to
be antigen specific, despite being linked primarily to IL-10 pro-
duction, suggesting the requirement for antigen presentation in
their regulatory function. A recent study demonstrated IL-10 pro-
ducing CD1dhigh B cells from the spleens of schistosome infected
mice could transfer immune regulation in a mouse model of
ovalbumin-induced asthma (VanDer Vlugt et al., 2012). A similar
population of B cells was found to be prevalent in the peripheral
blood of children infected with S. haematobium in Gabon (Van
Der Vlugt et al., 2012). The effect of schistosome infection on
responses to other infections and inflammatory stimuli will be
discussed in greater detail in another section.
ACTIVATION-INDUCED CELL DEATH AND FasL+ B LYMPHOCYTES
Interestingly, the CD5+ B cells in schistosome-infected mice also
expressed Fas ligand and were able to kill SEA-stimulated TH
cells by activation-induced cell death (AICD) (Lundy and Boros,
2002). AICD is a form of programmed cell death (apoptosis)
that is an important mechanism of immune regulation during
and after inflammatory reactions. Clusters of apoptotic cells were
found in the spleens and granulomas of schistosome infected
mice to a much greater extent than in spleens of uninfected
mice (Estaquier et al., 1997). Culture of cells extracted from
schistosome-infected mice demonstrated that CD4+ and CD8+
T cells spontaneously underwent apoptosis in vitro and were sen-
sitive to apoptosis induction in response to IL-10 and mitogenic
stimulation (Estaquier et al., 1997). A different study demon-
strated increases in in vivo CD4+ and CD8+ T cell apoptosis from
4 to 7 weeks of infection compared to later time points, sup-
porting the hypothesis that TH1 cells were more susceptible to
AICD than their TH2 counterparts during schistosome infection
(Fallon et al., 1998). In contrast, a study of human schistoso-
miasis indicated that T cells from patients with the less severe,
intestinal form of disease were susceptible to apoptosis while
T cells from patients with the more severe, hepatosplenic TH1
form of disease were resistant to egg antigen-induced apopto-
sis (Carneiro-Santos et al., 2000). In a more prolonged model
of natural murine Schistosoma mansoni infection, systemic sen-
sitivity to TH cell apoptosis commenced soon after egg deposition
(5 weeks), and progressed throughout the early granulomatous
stages (6–10 weeks), in parallel with increased inflammation, and
persisted at lower levels throughout the chronic, downmodulated
stage (12–16 weeks) of the infection (Lundy et al., 2001). Levels
of apoptosis exceeded 20% of the total CD4+ T cell population,
which was far in excess of the expected number of antigen-specific
cells, suggesting that a large number of bystander CD4+ T cells
may be eliminated during schistosome infection (Lundy et al.,
2001). Culture of splenocytes from infected and uninfected mice
with SEA led to TH cell apoptosis only in cells isolated from
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infected mice (Lundy et al., 2001). The three major lymphocyte
populations of the spleen, CD4+ and CD8+ T cells as well as
CD19+ B cells expressed the death-inducing molecule Fas ligand
(FasL, CD178) (Lundy et al., 2001). The staining of freshly iso-
lated splenocytes from 5 to 16 weeks infected mice demonstrated
that the number of surface FasL+ cells correlated with the level of
TH cell apoptosis at each time point (Lundy et al., 2001).
FasL expression on CD8+ and CD4+ T cells is not surprising
given that both T cell recognition of schistosome antigens and
FasL up-regulation are mediated through the TCR. FasL expres-
sion by B cells was a much rarer finding, and the schistosome
model provided some of the first evidence of the ability of iso-
lated B lymphocytes to kill TH cells in an SEA-dependent fashion
(Lundy et al., 2001; Lundy and Boros, 2002; Lundy, 2009). Culture
of splenocytes from 8 week-infected mice with SEA led to upreg-
ulated FasL expression on B and T cells and increased TH cell
apoptosis. Depletion studies indicated that the majority of TH cell
death was mediated by B cells rather than CD8+ CTL (Lundy
et al., 2001). In a follow up study, B cell FasL expression was
observed primarily on the splenic CD5+ B cell subset throughout
schistosome infection and was even observed on splenic CD5+ B
cells in uninfected mice (Lundy and Boros, 2002). Purified CD5+
B cells killed TH cells from schistosome-infected mice at a low
effector:target (0.5:1) ratio only when SEA was present (Lundy
and Boros, 2002). FasL expression on CD5+ B cells was stimu-
lated by culture with SEA and further enhanced when IL-4 and/or
IL-10 were added to the culture (Lundy and Boros, 2002). The
induction of IL-10 production by CD5+ B cells following expo-
sure to schistosome glycans may act in an autocrine manner to
induce higher FasL expression on these cells and suggests that
CD5+ B cells may have several mechanisms of immune suppres-
sion at their disposal (Velupillai et al., 1996a; Klinker and Lundy,
2012). Induced FasL expression and IL-10 production by CD5+ B
cells, which are well-documented to have autoreactive and poly-
reactive antibody specificities, may be an important mechanism
behind the correlations between schistosome infection and pro-
tection from autoimmunity and asthma described below (Lundy
et al., 2005; Lundy and Fox, 2009).
OTHER MECHANISMS OF IMMUNE REGULATION
Other cell types may also participate in downregulation of the
immune response to schistosome eggs. Granuloma macrophages
represent about 30 percent of the total cells in the lesion. Early
in the response to infection, macrophages and monocytes are
important in the elicitation of delayed-type hypersensitivity gran-
uloma formation and have cytotoxic effects on the miracidiae
(Boros and Warren, 1971a). However, as described above, expo-
sure to components of SEA results in alternative activation of
monocytes and macrophages as well as DC, and promotion
of the transition to a TH2 dominated immune response (Zhu
et al., 2012). In addition, exposure of monocytes/macrophages
to SEA leads to suppressive effects on SEA-induced T lympho-
cyte proliferation (Elliott and Boros, 1984). These macrophage
suppressive effects may be attributable to SEA-induced produc-
tion of IL-10, type 1 interferons and/or prostaglandin E2 (Elliott
et al., 1987, 1990; Atochina and Harn, 2005). An interesting study
of the effects of schistosome infection on chemically-induced
experimental colitis in mice demonstrated an immune regulatory
effect of F4/80+ macrophages that had migrated to the lamina
propria (Smith et al., 2007). These macrophages were not induced
by injection of schistosome eggs alone, and their mechanism of
action was reported to be independent of alternative activation
markers, interactions with TH2 and TREG cells, or production
of TGFβ or IL-10 (Smith et al., 2007). Schistosome infection
also induces production of IL-10 by DC that in turn can induce
the activation of FoxP3+ TREG cells (Liu et al., 2011). These
schistosome-induced DC transferred resistance to airway inflam-
mation following adoptive transfer in an ovalbumin-induced
model of asthma (Liu et al., 2011). Similar IL-10 production by
DC and DC-dependent induction of TREG cells was found fol-
lowing schistosome infection in the NOD mouse model of type 1
diabetes (Zaccone et al., 2009).
SCHISTOSOME INFECTION MODULATES IMMUNE
RESPONSES TOWARD OTHER ANTIGENS
The systemic immune modulatory and regulatory pathways
elicited by schistosome infection are not limited to antigens pro-
duced by adult schistosomes or their eggs (Harnett and Harnett,
2006; Helmby and Bickle, 2006; Kamal and El Sayed Khalifa,
2006; Zaccone et al., 2006). Bystander immune modulation by
helminths has become a topic of great interest because of its
negative impact on responses to vaccinations and pathogenic
co-infections (Kamal and El Sayed Khalifa, 2006). With over
200 million estimated cases of schistosome infection worldwide,
diminished responsiveness to protective vaccines and pathogenic
infections poses a major public health hurdle, and justifies the
support for global initiatives aimed at reducing schistosome infec-
tion (Borkow and Bentwich, 2000). Yet, as will be discussed,
schistosomes and other helminths have been correlated to protec-
tion from allergies and autoimmunity by many epidemiological
studies as well as experimental model systems and clinical trials
(Kamal and El Sayed Khalifa, 2006; Zaccone et al., 2006; Maizels,
2009).
RESPONSES TO VACCINATIONS AND CONCURRENT INFECTIONS
The switch from TH1- to a strong TH2-dominated immune
response that occurs during progression of schistosome infection
and egg granuloma formation has a negative impact on the abil-
ity of the host to respond correctly to intracellular pathogens.
As the infection becomes more chronic, the TH2 response gives
way to a highly regulatory immune response that can dampen
both TH1 and TH2 immunity, leaving the host very suscepti-
ble to both intracellular and extracellular microbes. While this
progression may be necessary to regulate liver toxicity and gran-
uloma formation caused by the schistosome eggs (see above),
it also causes significant morbidity and increased mortality in
infected individuals. Schistosome infection has been shown to
have preventive effects on immune responses elicited by vaccines
against tetanus toxoid in humans and diphtheria toxin as well
as Bacillus-Calmette-Guérin in mice (Sabin et al., 1996a; Haseeb
and Craig, 1997; Elias et al., 2005). These examples illustrate
altered humoral and cellular immune responses toward vaccines
and will most likely translate to many other types of vaccinations
including those against HIV, hepatitis viruses, Mycobacteriae spp.
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and malaria, significant pathogens that coexist in schistosome
endemic areas.
The interaction between schistosome and HIV infections is
of particular importance as the overlapping endemic regions for
these two infections persist. Cells from schistosome infected indi-
viduals are more susceptible to HIV-1 infection reportedly due
to IL-4 or IL-10 induced expression of the HIV co-receptors
CXCR4 and CCR5 on immune cells of schistosome infected sub-
jects (Shapira-Nahor et al., 1998; Kalinkovich et al., 1999; Secor
et al., 2003). Selective inhibition of the cytolytic response of CD8+
T cells for the HIVGag protein has also been noted in schistosome
infected individuals (McElroy et al., 2005). These findings could
be expected to increase cell–cell transmission and viremia in indi-
vidual patients, and therefore, to increase the person to person
transmission of HIV in schistosome endemic areas (Quinn et al.,
2000). However, studies of HIV viral load and disease progression
in schistosome infected individuals following de-worming have
yielded conflicting results (Lawn et al., 2000; Wolday et al., 2002;
Secor et al., 2004; Kallestrup et al., 2005). Susceptibility to HIV
infection and response of the virus to de-worming is undoubtedly
dependent on the stage and severity of the schistosome infec-
tion and the status of the immune response at the time of HIV
exposure. In contrast, schistosome egg excretion is increased by
T cell-mediated inflammation, and persons co-infected with HIV
had marked decreases in the number of excreted eggs (Doenhoff,
1997).
Another major public health concern is co-infection of schisto-
some infected individuals with liver tropic viruses such hepatitis
B and C (Kamal et al., 2004). Although there is evidence that
schistosome infection does not increase the incidence of hep-
atitis infection in endemic areas for both diseases, co-infections
in these regions are quite frequent (Larouze et al., 1987; Pereira
et al., 1994; Angelico et al., 1997). Interestingly, a study of liver
biopsies of patients infected with hepatitis C showed no signif-
icant impact of co-infection by schistosomes or the presence of
egg granulomas on virus-induced pathology (Helal et al., 1998).
However, a separate study focused instead on the liver pathol-
ogy of schistosome infected individuals, showed that co-infection
with hepatitis C led to much more severe liver damage includ-
ing cirrhosis and cancers that were not found in the absence of
HCV co-infection (Mohamed et al., 1998). Despite the lack of evi-
dence that schistosome co-infection changes the course of liver
pathology caused by hepatitis virus, some studies have shown
differences in TH cell cytokine responses toward viral antigens
in schistosome co-infected people and viral persistence (Kamal
et al., 2001; El-Kady et al., 2005). Schistosome co-infection sup-
pressed the TH1 response normally elicited by HCV infection
(Kamal et al., 2001; El-Kady et al., 2005). An improvement was
seen in the anti-viral response of a cohort of co-infected patients
following treatment with praziquantel to remove schistosomes
(Farghaly and Barakat, 1993). In an experimental model of hep-
atic virus infection, schistosome infected mice co-infected with
LCMV had an influx of activated CD8+ CTL cells expressing
IFNγ into the liver, which led to down regulation of the gran-
uloma TH2 response (Edwards et al., 2005). The end result of
LCMV co-infection was increased liver toxicity and viral repli-
cation in the schistosome infected mice (Edwards et al., 2005).
Thus, schistosomes and hepatotropic viruses have a complex rela-
tionship that generally leads to alterations in immune responses
to both pathogens, and worse prognosis.
Schistosome infections can also influence the immune
response toward other pathogens. Mice co-infected with
Mycobacterium avium and Schistosoma mansoni had a shift to
TH2 dominated cytokine responses toward mycobacterial anti-
gens even when the M. avium infection was established first
(Sacco et al., 2002). Similar results were seen in a co-infection
model of S. mansoni and M. leprae in mice (Frantz et al., 2010).
As noted above, schistosome infected mice responded poorly to
vaccination with Bacillus-Calmette-Guerin, yet in the M. leprae
study, vaccination with a DNA vaccine encoding the heat shock
protein 65 molecule did induce a protective response in S. man-
soni infected mice (Elias et al., 2005; Frantz et al., 2010). It remains
to be seen whether such a strategy could be effective in co-infected
humans, particularly those individuals who are also infected with
the HIV virus. A study of the progression of active tuberculo-
sis in HIV-infected individuals revealed a correlation between
co-infection with schistosomes and increased active tuberculo-
sis (Brown et al., 2006). A notable increase in susceptibility to
malaria infection has also been described in people infected with
schistosomes and other intestinal helminths (Nacher et al., 2002b;
Sokhna et al., 2004). At the same time, schistosome infection may
play a beneficial role in limiting the more severe cerebral form
of malaria infection (Nacher et al., 2002a; Waknine-Grinberg
et al., 2010). Co-infection of mice with Plasmodium chabaudi and
S. mansoni led to reciprocal alterations in the immune response
to either pathogen (Helmby et al., 1998). The widespread pres-
ence of schistosomes in areas that are endemic for these other
major pathogens is likely to impede progress in designing effective
vaccination and eradication strategies in the near future.
SCHISTOSOMES AND THE HYGIENE HYPOTHESIS
While major attempts at de-worming in schistosome endemic
areas are important and worthwhile public health goals, there are
substantial epidemiological and experimental data that indicate
that this could lead to an increased risk for autoimmune diseases
and allergy. The “hygiene hypothesis” asserts that the measurable
increase in both TH1 and TH2 immune-mediated diseases that
has occurred in the last century in developed nations is a result
of improvements in sanitation that have led to increased sensitiv-
ity of the immune system to self-antigens and/or allergens (Gale,
2002; Airaghi and Tedeschi, 2004; Rook, 2012). Although the
hygiene hypothesis was originally focused on the opposing roles
of TH1 and TH2 immune responses that were established in child-
hood on later immune challenges, the hypothesis came under
scrutiny when it was realized that both TH1 (type 1 diabetes)
and TH2 (allergy) immune-mediated inflammatory diseases were
rising in the same geographical areas and demographic groups
(Stene and Nafstad, 2001). More telling was the fact that the
prevalence of asthma and schistosome infections did not over-
lap despite both provoking heavily TH2-biased immune responses
(Yazdanbakhsh et al., 2001). Now that it is understood that
chronic helminth infections also stimulate a highly regulatory
immune response that affects both TH1 and TH2 reactions, a role
for schistosomes and other worms in the hygiene hypothesis fits
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better with the epidemiological data (Wynn et al., 1997; Araujo
et al., 2004; Maizels, 2009). This intriguing correlation has led
to series of experiments in mice as well as clinical trials to test
the ability of helminths to modulate autoimmune diseases and
asthma.
AUTOIMMUNE DISEASES AND SCHISTOSOMES
Type 1 diabetes (T1D) is an autoimmune disease that has risen
in prevalence in developed and developing nations as hygiene
has improved, and is rarely found in areas endemic for schis-
tosomiasis (Zaccone et al., 2008). Cercarial infection of NOD
mice that spontaneously develop T1D with Schistosoma mansoni
prior to T1D disease development led to granuloma formation in
the pancreas and a delay in hyperglycemia (Cooke et al., 1999).
The same study showed that weekly injection of schistosome eggs
led to suppression of anti-insulin IgG antibody production and
decreased blood glucose levels in comparison to control NOD
mice (Cooke et al., 1999). These effects were later shown to be
dependent on the timing of administration and could be recapit-
ulated by treatment with soluble antigens extracted from adult
worms as well as with SEA (Zaccone et al., 2003). Splenic T
cells from egg-sensitized NOD mice produced similar levels of
IFNγ, but much higher amounts of IL-4, IL-5, IL-13, and IL-
10 in response to SEA challenge than did cells from control
mice (Zaccone et al., 2003). Unlike soluble antigens from adult
worms, SEA cooperated with bacterial lipopolysaccharide (LPS)
in mediating a shift away from IL-12 production and toward IL-
10 production in bone marrow-derived DCs from NOD mice
(Zaccone et al., 2003). Adoptive transfer of splenocytes from
SEA-treated NOD mice failed to induce T1D in NOD. SCID
recipients, an effect attributed to TGFβ-dependent induction of
FoxP3+/GITR+/CD25+ TREG cells (Zaccone et al., 2003, 2009).
Correlative studies involving schistosome infection have been
reported in mouse models of Grave’s disease and autoimmune
arthritis (Nagayama et al., 2004; Osada et al., 2009; Song et al.,
2011).
A series of experiments has been conducted in the EAE
model of multiple sclerosis in which susceptible mouse strains
are immunized with peptides derived from proteolipid protein
or myelin oligodendrocyte glycoprotein emulsified in complete
Freund’s adjuvant. An initial study demonstrated that prior infec-
tion of mice with Schistosoma mansoni led to reduced incidence
of EAE as measured by paralysis and delayed infiltration of
CD3+ T cells and F4/80+ macrophages into the brain and spinal
cord (La Flamme et al., 2003). These effects were attributed to
reduced levels of TNFα, IFNγ and IL-12 produced by cells from
schistosome-infected mice (La Flamme et al., 2003). Very simi-
lar results were obtained using schistosome eggs to pretreat mice
prior to EAE disease induction (Sewell et al., 2003). In the lat-
ter study, egg injection within the first two days after induction
of EAE led to a significant delay in the onset of paralysis but
became less effective as the time after disease induction increased
(Sewell et al., 2003). The EAE model can be mediated by either
TH1 or TH17 cells, which are both sensitive to immune regula-
tion by IL-4, and it was shown that the effects of schistosome
eggs on EAE were dependent on the major signaling transcription
factor downstream of IL-4 receptor, STAT6 (Sewell et al., 2003).
Protection from EAE has also been demonstrated using either
unfractionated SEA or purified LNFPIII derived from schisto-
some eggs (Zheng et al., 2008; Zhu et al., 2012). Despite the
findings that a delay in exposure to schistosomes or their prod-
ucts can prevent therapeutic effects on EAE, the data in humans
appears to be more promising. A small cohort of patients that
had previously been diagnosed with MS and then developed
eosinophilia related to intestinal helminth infection was identi-
fied in Argentina (Correale and Farez, 2007). These patients had
significantly fewer exacerbations of MS upon 5-year follow up
thanmatched control patients whowere uninfected (Correale and
Farez, 2007). The peripheral blood of the infected MS patients
had a higher frequency of IL-10 and TGFβ producing cells than
controls, and significantly reduced numbers of IL-12 and IFNγ
producers (Correale and Farez, 2007). Further studies of this
cohort indicated that IL-10 producing B cells were prevalent in
the infected MS patients (Correale et al., 2008). B cells and DCs
from infected patients expressed TLR2 at high levels and sup-
pressed TH1 and TH17 cell cytokine production while promoting
TH2 cytokines after treatment with TLR2 ligands (Correale and
Farez, 2009).
It has also been suggested that the greatly increased incidence
of the inflammatory bowel diseases (IBD), ulcerative colitis and
Crohn’s disease, in developed countries may be due to reduced
exposure to helminths including Schistosomamansoni (Weinstock
and Elliott, 2009; Elliott and Weinstock, 2012). The gut mucosa
is a site of exposure of the host to many potentially harmful
microbes, as well as amajority of non-harmful commensal organ-
isms. In order to maintain a balanced immune response in the
gut mucosa, there are specialized lymphoid structures and cell
populations that generally have a highly regulatory phenotype
(Rubtsov et al., 2008; Maynard and Weaver, 2009). The devel-
opment of IBD is known to be strongly suppressed by IL-10
and regulatory T cells as evidenced by animal models involv-
ing circumvention of these mechanistic pathways (Rubtsov et al.,
2008; Glocker et al., 2009). As noted above, both IL-10-producing
CD5+ B cells and FoxP3+ TREG cells are stimulated by infec-
tion with schistosomes. In particular, CD5+ B cells are normally
resident in the mucosa and have high regulatory potential due
to inducible expression of IL-10, FasL, regulatory natural anti-
bodies and other mechanisms of immune regulation (Klinker
and Lundy, 2012). Direct experimental evidence of a role for
schistosome and other helminth infections in the suppression of
IBD has come from experimental mouse models (Smith et al.,
2007; Weng et al., 2007). Mice that were infected with cercariae
8 weeks prior to the elicitation of colitis in the dextran sodium
sulfate (DSS) model did not display weight loss, bloody stools
or shortening of colon length as was detected in uninfected con-
trol mice (Smith et al., 2007). In addition to induction of IL-10
and TGFβ, neither of which was solely responsible for protection
from colitis, schistosome infection led to increased infiltration of
macrophages into the intestinal lamina propria that were required
for immune suppression (Smith et al., 2007). Although exposure
to schistosome eggs did not elicit protection from orally-induced
DSS colitis, this treatment was effective in the trinitrobenzene
sulfonic acid (TNBS) model that involves the more localized
rectal administration of the eliciting agent (Elliott et al., 2003).
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Similarly, administration of worm proteins extracted from adult
schistosomes in the TNBS colitis model as much as 6 h after rectal
administration of TNBS led to decreased inflammation (Ruyssers
et al., 2009). The worm antigen treatment was accompanied by
increased colonic expression of IL-10, TGFβ, and IL-5 but dimin-
ished expression of IFNγ, IL-12, IL-17, and IL-4 (Ruyssers et al.,
2009). The epidemiological and experimental data outlined above
was used as justification for Phase I open-label trials and Phase
II randomized, controlled clinical trials using ingestion of ova
from the pig whipworm, Trichuris suis, to treat ulcerative coli-
tis (Summers et al., 2003, 2005). Oral intake of 2500 T. suis ova
biweekly for 12 weeks led to clinical improvement in 43% of ova-
treated patients compared to 17% improvement using the same
measures in placebo-control recipients at the end of the 12 weeks
treatment period (Summers et al., 2005). Therapy with T. suis
eggs may have several advantages over similar treatment with eggs
from other helminths since the T. suis eggs are easy to obtain and
store, and do not permanently colonize humans or invade into
tissues where they could become pathogenic (Weinstock et al.,
2002).
ASTHMA
There was an early expectation that an association of increased
incidence of allergic asthma and other atopic disease responses in
individuals with schistosoma infections would exist, due to the
strongly skewed TH2 immune response environment induced by
SEA. However, this was not the case and individuals with schis-
tosoma infection were shown to have lower incidence of allergic
asthma compared to those without (Yazdanbakhsh et al., 2001;
Araujo and De Carvalho, 2006). While this effect does not appear
to be limited to schistosomes, they are the most widely endemic
infectious organism among helminths and the most thoroughly
studied. Initial data suggested that the responses could be corre-
lated to increased levels of IL-10 and subsequently to TREG cells
that are generated during chronic schistosoma infection (Cardoso
et al., 2006; Yang et al., 2007). Interestingly, recent data immuniz-
ing animals to a specific schistosome antigen, Sm22.6, demon-
strated that allergen specific IgE as well as TH2 cytokines were
reduced and correlated with generation of TREG cells (Cardoso
et al., 2010). However, subsequent additional studies have demon-
strated that numerous B cell associated responses may also con-
tribute to a regulatory environment for the development and
regulation of allergic responses, including both B cell-derived IL-
10 production and altered T cell activation (Amu et al., 2010;
Van Der Vlugt et al., 2012). In these studies, B cell transfer
experiments demonstrated that CD1dhi B cells from schistosome-
infected animals could modulate allergen-induced responses in
an IL-10-dependent manner that stimulated TREG cells in the
recipients (Amu et al., 2010; Van Der Vlugt et al., 2012). A similar
population of CD1dhi IL-10 producing B cells was found in the
peripheral blood of Schistosoma haematobium-infected Gabonese
children compared to uninfected children (Van Der Vlugt et al.,
2012). Importantly, in the latter study a reduction in the BREG
population was reduced after treatment of the schistosome infec-
tion (Van Der Vlugt et al., 2012). In some B cell transfer studies
involving cells isolated from helminth infected mice, there were
also notable suppressive effects on asthma that were independent
of IL-10, but the mechanisms were not determined (Wilson et al.,
2010; Van Der Vlugt et al., 2012). Using animal models of chronic
allergic responses it was observed that lung CD5+ B cells could
express FasL and regulate allergic responses by a FasL-mediated
mechanism similar to that previously observed in schistosome
infection (Lundy and Boros, 2002; Lundy et al., 2005).What is not
clear from these studies is how the regulated immune response
controlled by B cells from schistosome infections is able to cross
react to allergens and elicit non-specific regulatory functions.
Interestingly, since B cells can provide a TH2-skewed APC func-
tion during allergic responses, there may also be other aspects of B
cell biology that alters the direction of TH2 type allergic immune
responses (Lindell et al., 2008). It is conceivable that one aspect
of B cell regulation might be related to the ability to alter the
cytokine environment and indirectly affect activation of regula-
tory T cells. Thus, the infection with Schistosoma has a systemic
effect on the development of allergic responses that includes an
interrelated generation of numerous regulatory lymphocyte pop-
ulations, both B and T cells, that may impact several aspects of
immunity including vaccination responses.
THERAPEUTIC POTENTIAL OF SCHISTOSOME-DERIVED
IMMUNOMODULATORS
A challenge moving forward with efforts to eradicate schisto-
somes will be to find ways of selectively replacing their poten-
tially beneficial immune modulatory effects on allergy and
autoimmunity, while preserving immune responses toward other
pathogenic microorganisms. The correlations between chronic
exposure to schistosome eggs and immune downregulation have
led to interest in finding egg-derivedmolecules that can therapeu-
tically mediate suppression of immune responses (Harnett and
Harnett, 2010). It has long been recognized that SEA is a major
mediator of the shift in immune response from the proinflam-
matory and TH1 reactions prevalent early after infection toward
the TH2-dominated response that prevails in the acute phase of
egg granuloma formation. SEA is a highly complex mixture of
components including proteins, nucleic acids, lipids, glycolipids,
complex carbohydrates, and glycoprotein molecules that can have
direct or indirect effects on both innate and adaptive immune
responses. Schistosome LNFPIII and glycoprotein ω-1 have been
particularly interesting candidate molecules that contribute to
immune modulation, yet there may be many other molecules in
SEA or derived from other helminths that could hold therapeutic
potential (Harnett and Harnett, 2010).
LACTO-N-FUCOPENTAOSE III
The pentameric, sialyl Lewisx containing glycan, lacto-N-
fucopentaose III (LNFPIII, CD15), is a major carbohydrate
component of SEA (Figure 2A). It was originally identified by
antibody binding on human tumor cells and later found to be
expressed by many human adult and fetal tissues, particularly in
the mucosa (Brockhaus et al., 1982; Combs et al., 1984; Velupillai
and Harn, 1994). As described above and shown in Figure 2B, the
LNFPIII found in SEA was originally shown to have direct effects
on the stimulation of IL-10 production by CD5+ B cells in vitro
(Velupillai et al., 1997). LNFPIII also drives a strong TH2 response
toward protein antigens with which it is conjugated when injected
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FIGURE 2 | Structure and mechanisms of action of lacto-N-fucopentaose
III protein conjugates on CD5+ B cells and dendritic cells. (A) The
lacto-N-fucopentaose III (LNFPIII) molecule is a pentameric glycan consisting
of the trimeric sialyl Lewisx motif (green triangle) linked to a beta-galactose
and glucose dimer. For in vitro and in vivo studies, the glycan conjugated
proteins have been purified from soluble egg antigen (SEA) or manufactured
by linkage to a carrier protein molecule (bovine serum albumin, dextran,
ovalbumin) using biochemical crosslinkers. (B) LNFPIII conjugates have direct
effects on proliferation and IL-10 production by CD5+ B cells. Dendritic cells
(DC) respond to LNFPIII with altered antigen presenting capacity that favors
TH2 induction. Activation of DC by LNFPIII is mediated through TLR4 and/or
DC-SIGN, while the receptors for LNFPIII on CD5+ B cells have not yet been
identified. Treatment of mice with LNFPIII protein conjugates has led
to decreased disease progression in experimental autoimmune
encephalomyelitis (EAE), asthma and psoriasis models, and led to prolonged
heart allograft survival in a transplantation model. DC-SIGN, dendritic
cell-specific intracellular adhesion molecule-3-grabbing non-integrin;
TLR4, toll-like receptor 4; APC, antigen presenting cell.
into mice (Okano et al., 2001; Faveeuw et al., 2002). Subcutaneous
injection of a dextran-conjugated LNFPIII compound into psori-
asis susceptible fsn/fsn mice prior to disease onset was shown to
have a preventive effect on the formation of skin lesions (Atochina
and Harn, 2006). LNFPIII has also been shown to be therapeutic
in a mouse model of multiple sclerosis, and it prolonged the sur-
vival of allogeneic heart transplants in mice (Dutta et al., 2010;
Zhu et al., 2012). LNFPIII skews the antigen presenting capacity
of dendritic cells (DC) toward CD4+ but not CD8+ T cells (Wang
et al., 2010). Treatment of spleen-derived DC from naïve mice
with LNFPIII led to increases in MHC Class II and CD40 surface
expression similar to the effects seen after bacterial lipopolysac-
charide (LPS) treatment (Wang et al., 2010). However, LNFPIII
induced higher expression of CD86 and lower expression of CD80
than LPS resulting in a dramatic difference in the ratio of these
agonists for CD28 and CTLA4 molecules expressed by T cells
(Wang et al., 2010). In coculture experiments, the LNFPIII treated
DC preferentially induced IL-4 production fromOT-II transgenic
TH cells isolated from the spleens of naïve mice (Wang et al.,
2010). Details of the signaling effects downstream of LNFPIII
treatment in DC has recently been well reviewed (Harnett and
Harnett, 2010). LNFPIII signaling is dependent on TLR4, the
receptor for LPS, but downstream signaling is significantly dif-
ferent between the two ligands particularly in the ERK and MAP
kinase pathways and the mechanism of activation of the tran-
scription factor NFκB (Thomas et al., 2005; Wang et al., 2010).
In contrast to LPS stimulation, LNFPIII signals independently
of MyD88 and does not induce degradation of the inhibitor of
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NFκB (Thomas et al., 2005). A putative mechanism for this dif-
ference involves the binding of LNFPIII to C-type lectin receptors
such as DC-specific ICAM-3 grabbing non-integrin (DC-SIGN)
by the Lewisx motif (Van Liempt et al., 2004, 2007; Singh et al.,
2009). It has been shown that activation of C-type lectins through
binding of antibodies that are glycosylated with Lewisx containing
glycans is a mechanism of immune suppression induced by IVIG
treatment, a therapy for immune thrombocytopenic purpura and
other diseases (Anthony et al., 2008, 2012).
GLYCOPROTEIN ω-1
In the case of treatment for autoimmune diseases that are medi-
ated by TH1 or TH17 immune responses, it may be sufficient to
skew the response toward the TH2 cytokine, IL-4, which has an
inhibitory effect on IL-12 and IL-17 production. The SEA-derived
T2 ribonuclease omega-1 (ω-1) has a direct effect on antigen pre-
senting cells that supports TH2 polarization (Everts et al., 2009,
2012; Steinfelder et al., 2009). Purified and recombinant ω-1 sup-
pressed the ability of LPS to induce IL-12 secretion from DC as
well as their ability to induce IFNγ-producing TH1 cells in cocul-
ture experiments (Everts et al., 2009; Steinfelder et al., 2009).
Injection of purified ω-1 into 4get/KN2 mice demonstrated that
ω-1 could prime TH2 responses in vivo and further experiments
showed that TH2 induction was independent of the IL-4R sug-
gesting that the effects of ω-1 on TH2 priming were direct (Everts
et al., 2009). Like LNFPIII, ω-1 is glycosylated with sialyl Lewisx
motifs, and the TH2 inducing capacity of ω-1 was shown to be
dependent on glycosylation as well as the ribonuclease activity of
the protein (Meevissen et al., 2010; Everts et al., 2012). Treatment
of DC with SEA or purified ω-1 glycoprotein caused changes to
the adherence of DC to plastic dishes and disrupted interactions
with antigen-specific TH cells (Steinfelder et al., 2009). Antibody
neutralization and studies performed in mice with deficiencies
in the mannose receptor indicated that ω-1 was dependent on
the mannose receptor, but not on DC-SIGN, for uptake into
DC in vitro and TH2 polarization in vivo (Everts et al., 2012).
Treatment of NOD mice with ω-1 led to global increases in the
proportion of TH1, TH17, and TH2 cells compared to untreated
control mice, as well as a marked induction of FoxP3+CTLA4+
TREG cells (Zaccone et al., 2011). The induction of FoxP3 expres-
sion byω-1 was dependent on the functions of TGFβ and retinoic
acid (Zaccone et al., 2011). It has not been reported whether treat-
ment withω-1 causes reduced or delayed development of diabetes
in the NOD mice. Thus, both the glycoprotein ω-1 and the gly-
can LNFPIII components purified from SEA have demonstrable
effects on adaptive immune parameters making each molecule
a strong candidate for development of helminth-based immune
therapeutics.
SUMMARY AND CONCLUDING REMARKS
Although nearly every person may have been expected to be
infected by a helminth in their lifetime just a century ago, heroic
eradication efforts have all but eliminated helminth infection
from many areas and brought the infection rate down to an
estimated 10–20% of people worldwide. This has led to vast
improvements in the quality of life for billions of people, and
will have great benefits for combatting other major infections.
Several regulatory populations of lymphocytes are activated as
the infection becomes chronic and these diminish the responses
of schistosome antigen-specific effector T helper cells, and limit
granuloma formation around newly deposited eggs. The chronic
nature of schistosome-induced immune modulation can also
affect immune responses toward other antigen sources, leading
to poorer reactions to subsequent infections by other microbes.
Also accompanying the shift in worm infection rates have been
measurable increases in the rates of hyper-inflammatory dis-
eases including allergies, asthma, andmany autoimmune diseases.
Chronic helminth infections may drive immune suppression
toward allergens and self-antigens, thus potentially explaining the
lower incidence of allergies, asthma and autoimmunity in schisto-
some endemic areas. Studies of the cellular and molecular mech-
anisms underlying schistosome-induced immune suppression in
mice have supported the importance of regulatory T lymphocytes
and the effector cytokine TGFβ as mediators of suppression. The
schistosome infection model has also been instrumental in the
discovery of immune regulatory functions of B cells including IL-
10 production, and expression of the death-inducing molecule
Fas ligand. IL-10-producing B cells may mediate cooperative
effects with regulatory T cells, while FasL+ B cells have been
shown to have antigen-specific killer effects on T helper cells in
models of asthma and autoimmunity. The data from adoptive
cell transfer studies gives striking evidence that schistosomes do
have cross-regulatory effects on autoimmunity and asthma. The
goal as we move forward will be to find ways to mimic or replace
the protective aspects of helminth infections, while continuing to
improve hygienic conditions in endemic areas.
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